Results 11 to 20 of about 39,887 (295)
Dementia with Lewy bodies: Challenges in the diagnosis and management
Objective: Dementia with Lewy bodies is the second most common form of neurodegenerative dementia in older age yet is often under-recognised and misdiagnosed.
Kai Sin Chin +2 more
exaly +2 more sources
Inflammation in dementia with Lewy bodies
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of dementia, behind Alzheimer's disease (AD). The profile of inflammation in AD has been extensively researched in recent years, with evidence that chronic peripheral ...
Jay Amin +11 more
doaj +3 more sources
Advances in dementia with Lewy bodies [PDF]
Dementia with Lewy bodies (DLB) is a clinical diagnosis representing a specific presentation of a pathological α-synucleinopathy (Lewy body disease). DLB is one entity under the broader term Lewy body dementia , which also includes Parkinson’s disease ...
Melissa J. Armstrong
doaj +3 more sources
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies [PDF]
Dementia with Lewy bodies is characterized by the accumulation of Lewy bodies and Lewy neurites in the CNS, both of which are composed mainly of aggregated α-synuclein phosphorylated at Ser129.
Marti Colom-Cadena +2 more
exaly +2 more sources
Dementia With Lewy Bodies: A Review of Disease-Modifying Therapies for α-Synucleinopathies [PDF]
Aims: The global demographic transition has led to a growing ageing population. Neurodegenerative disease prevalence is high in the elderly, as aged brains accumulate molecular and cellular damage.
Bhattacharyya, Sharmi, Dar, Arzoo
core +2 more sources
Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies
OBJECTIVE Parkinson disease dementia (PDD) and dementia with Lewy bodies (DLB) have overlapping clinical and pathologic features. Recurrent visual hallucinations (RVH) are common in both disorders.
Urs P Mosimann +2 more
exaly +2 more sources
Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies
This article reviews the cholinergic changes in Parkinson's disease and dementia (PDD) and dementia with Lewy bodies (DLB), their potential clinical implications, and the available evidence for cholinesterase inhibitors in the treatment of PDD and DLB ...
Dag Aarsland +2 more
exaly +2 more sources
Objective: The aim of this paper is to summarise recent clinical and research findings with regard to dementia with Lewy bodies (DLB). Method: A literature review (Medline) was carried out, as well as a review of reports of recent DLB symposia of ...
McKeith I; O'Brien J
core +4 more sources
Dementia with Lewy bodies [PDF]
Objective: The aim of this paper is to summarise recent clinical and research findings with regard to dementia with Lewy bodies (DLB). Method: A literature review (Medline) was carried out, as well as a review of reports of recent DLB symposia of international meetings and of other relevant papers and data known to the authors.
I, McKeith, J, O'Brien
openaire +14 more sources
The broad importance of dementia is undisputed, with Alzheimer's disease justifiably getting the most attention. However, dementia with Lewy bodies and Parkinson's disease dementia, now called Lewy body dementias, are the second most common type of degenerative dementia in patients older than 65 years.
Walker, Zuzana +3 more
openaire +5 more sources

